{"id":"https://openalex.org/W2982232673","doi":null,"title":"Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation","display_name":"Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W2982232673","mag":"2982232673","pmid":"https://pubmed.ncbi.nlm.nih.gov/31141852"},"language":"en","primary_location":{"id":"pmid:31141852","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31141852","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066272149","display_name":"Seemal R. Desai","orcid":"https://orcid.org/0000-0002-3022-5169","observed_orcids":["https://orcid.org/0000-0002-3022-5169"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seemal Desai","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086341108","display_name":"Elo\u00edsa Leis Ayres","orcid":"https://orcid.org/0000-0003-0533-4950","observed_orcids":["https://orcid.org/0000-0003-0533-4950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eloisa Ayres","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077072578","display_name":"Hana Bak","orcid":"https://orcid.org/0000-0002-7901-8080","observed_orcids":["https://orcid.org/0000-0002-7901-8080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hana Bak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006070488","display_name":"Megan C. Manco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megan Manco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113361302","display_name":"Stephen Lynch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Lynch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028408613","display_name":"Susana Raab","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susana Raab","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090551353","display_name":"Ana Du","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Du","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090173210","display_name":"Des Tenee Green","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DesTenee Green","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026142971","display_name":"Cezary Skobowiat","orcid":"https://orcid.org/0000-0002-3881-0231","observed_orcids":["https://orcid.org/0000-0002-3881-0231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cezary Skobowiat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079916806","display_name":"Janet Wangari\u2010Talbot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet Wangari-Talbot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103124633","display_name":"Qian Sheng Zheng","orcid":"https://orcid.org/0000-0003-3701-2657","observed_orcids":["https://orcid.org/0000-0003-3701-2657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Zheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.2731,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.97781071,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"18","issue":"5","first_page":"454","last_page":"459"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.7979000210762024,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.7979000210762024,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.19910000264644623,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tranexamic-acid","display_name":"tranexamic acid","score":0.9789999723434448},{"id":"https://openalex.org/keywords/kojic-acid","display_name":"kojic acid","score":1.0},{"id":"https://openalex.org/keywords/nicotinamide","display_name":"nicotinamide","score":1.0},{"id":"https://openalex.org/keywords/facial-serum","display_name":"facial serum","score":0.8050000071525574},{"id":"https://openalex.org/keywords/melasma","display_name":"melasma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/post-inflammatory-hyperpigmentation","display_name":"post-inflammatory hyperpigmentation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":0.8500000238418579},{"id":"https://openalex.org/keywords/topical-therapy","display_name":"topical treatment","score":0.5360000133514404},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.546999990940094},{"id":"https://openalex.org/keywords/fitzpatrick-skin-type","display_name":"Fitzpatrick skin type","score":0.7620000243186951},{"id":"https://openalex.org/keywords/epidermal-melanocytes","display_name":"epidermal melanocytes","score":0.7670000195503235},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C2776677263","wikidata":"https://www.wikidata.org/wiki/Q305190","display_name":"Melasma","level":2,"score":0.974114179611206},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9419900178909302},{"id":"https://openalex.org/C2776728111","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Hyperpigmentation","level":2,"score":0.8010760545730591},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7778860330581665},{"id":"https://openalex.org/C2909408332","wikidata":"https://www.wikidata.org/wiki/Q192423","display_name":"Niacinamide","level":4,"score":0.7276996374130249},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6256617307662964},{"id":"https://openalex.org/C2779538156","wikidata":"https://www.wikidata.org/wiki/Q416285","display_name":"Kojic acid","level":4,"score":0.6109769940376282},{"id":"https://openalex.org/C2779637338","wikidata":"https://www.wikidata.org/wiki/Q418666","display_name":"Tranexamic acid","level":3,"score":0.5585188865661621},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30383065342903137},{"id":"https://openalex.org/C87554066","wikidata":"https://www.wikidata.org/wiki/Q85942926","display_name":"Tyrosinase","level":3,"score":0.25055086612701416},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.20862823724746704},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1675836741924286},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2991743468","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Blood loss","level":2,"score":0.0},{"id":"https://openalex.org/C2779728014","wikidata":"https://www.wikidata.org/wiki/Q192423","display_name":"Nicotinamide","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005148","descriptor_name":"Facial Dermatoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005148","descriptor_name":"Facial Dermatoses","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011753","descriptor_name":"Pyrones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011753","descriptor_name":"Pyrones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017495","descriptor_name":"Hyperpigmentation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017495","descriptor_name":"Hyperpigmentation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:31141852","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31141852","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial"},{"id":"mag:2982232673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31141852","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402106856","https://openalex.org/W1560566815","https://openalex.org/W4230354173","https://openalex.org/W3036409259","https://openalex.org/W2770216418","https://openalex.org/W4402106813","https://openalex.org/W4306836265","https://openalex.org/W2087731333","https://openalex.org/W3034141021","https://openalex.org/W4401775610"],"abstract_inverted_index":{"Background:":[0],"Stubborn":[1],"dyschromia":[2],"such":[3],"as":[4,64,182,193],"melasma":[5],"and":[6,91,103,125,127,134,145,165,175,199,212],"post-inflammatory":[7],"hyperpigmentation":[8,104],"(PIH)":[9],"are":[10],"leading":[11],"causes":[12],"for":[13,96,216],"cosmetic":[14],"consultation.":[15],"Topical":[16],"treatment":[17,150,214],"is":[18,43,209],"challenging,":[19],"using":[20],"a":[21,39,65,76,80,187],"range":[22],"of":[23,52,148,159,235],"modalities,":[24],"to":[25,45,195],"stop,":[26],"hinder,":[27],"and/or":[28],"prevent":[29],"steps":[30],"in":[31,56,72,99,105,156,223],"the":[32,50,149,157,206,233],"pigment":[33],"production":[34],"process.":[35],"Tranexamic":[36],"acid":[37],"(TXA),":[38],"potent":[40],"plasmin":[41],"inhibitor,":[42],"proposed":[44],"control":[46],"pigmentation":[47,71],"by":[48,142,184,190,231],"inhibiting":[49],"release":[51],"inflammatory":[53],"mediators":[54],"involved":[55],"triggering":[57],"melanogenesis.":[58],"TXA":[59,228],"has":[60],"been":[61],"recently":[62],"introduced":[63],"topical":[66,82],"therapy":[67],"aimed":[68],"at":[69,118,172],"reducing":[70],"melasma.":[73,221],"Methods:":[74],"In":[75],"12-week":[77],"clinical":[78,130],"study,":[79],"novel,":[81],"facial":[83],"serum":[84],"containing":[85],"3%":[86],"TXA,":[87],"1%":[88],"kojic":[89],"acid,":[90],"5%":[92],"niacinamide":[93],"was":[94,139,169],"evaluated":[95,141],"its":[97],"effectiveness":[98],"treating":[100],"melasma,":[101,162],"PIH,":[102,160],"Brazilian":[106],"female":[107],"subjects":[108],"with":[109],"Fitzpatrick":[110],"skin":[111,163,166],"types":[112],"I-IV.":[113],"Efficacy":[114],"evaluations":[115],"were":[116],"performed":[117],"pre-treatment":[119,197],"baseline,":[120],"weeks":[121],"2,":[122],"4,":[123],"8,":[124],"12,":[126],"included":[128],"expert":[129],"grading,":[131],"bio-instrumental":[132],"measurements,":[133],"self-assessment":[135],"questionnaires.":[136],"Cutaneous":[137],"tolerability":[138],"also":[140],"assessing":[143],"subjective":[144],"objective":[146],"irritation":[147],"area.":[151],"Results:":[152],"A":[153],"significant":[154,188],"improvement":[155],"appearance":[158],"hyperpigmentation,":[161],"texture,":[164],"tone":[167],"homogeneity":[168],"observed":[170],"beginning":[171],"week":[173,178,191],"2":[174],"continued":[176],"through":[177],"12.":[179],"Melanin":[180],"index,":[181],"measured":[183],"Mexameter\u00ae,":[185],"demonstrated":[186],"decrease":[189],"12":[192],"compared":[194],"both":[196],"baseline":[198],"control.":[200],"Conclusions:":[201],"The":[202],"findings":[203],"suggest":[204],"that":[205,227],"test":[207],"product":[208],"an":[210],"effective":[211],"well-tolerated":[213],"option":[215],"addressing":[217],"hyperpigmentary":[218],"conditions,":[219],"including":[220],"Additional":[222],"vitro":[224],"data":[225],"suggests":[226],"may":[229],"act":[230],"mediating":[232],"inhibition":[234],"PGE2-stimulated":[236],"human":[237],"epidermal":[238],"melanocytes.":[239],"J":[240],"Drugs":[241],"Dermatol.":[242],"2019;18(5):454-459.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-11-01T00:00:00"}